Key result
Stroke and bleeding risk stratification tools, particularly the CHA2DS2-VASc and HAS-BLED scores, are essential for guiding appropriate oral anticoagulant therapy in patients with atrial fibrillation.
Careful application of stroke and bleeding risk scores, particularly in borderline cases (CHA2DS2-VASc of 1), is essential for optimizing oral anticoagulation decisions in patients with atrial fibrillation.
Atrial fibrillation (AF) is a common arrhythmia managed by many physicians in a variety of clinical settings. One of the most important clinical decisions related to effective AF management centers upon the need to perform accurate thromboembolic risk stratification followed by effective management decisions that align with established guidelines. This manuscript will review the present state of the art and provide guidance to physicians to enhance patient outcomes.
No takes yet. Share an insight, caveat, or question.
Thomas F. Deering (2017) conducted a review in Atrial Fibrillation. Stroke and bleeding risk stratification tools was evaluated. Stroke and bleeding risk stratification tools, particularly the CHA2DS2-VASc and HAS-BLED scores, are essential for guiding appropriate oral anticoagulant therapy in patients with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: